Chat with Michael Werner of ARM on Cures Act regenerative medicine provisions
One of the hottest topics in the world of stem cells this year has been the REGROW ACT and at a larger level the movement for changes in FDA oversight of investigational regenerative medicine therapies (see my past posts on […]